Infectious Disease Advisor

Hospitalization Burden of Injection Drug Use-Related Infections Remains High in TN

Tennessee hospitalizations for injection drug use-related infections remain a major clinical and economic burden despite rates plateauing after 2018.

Use of Gilead's HIV prevention shot rises, but US insurance gaps remain

Use of Gilead Sciences' Yeztugo, a twice-yearly injection to prevent HIV infection, has climbed since its June launch, but U. health providers say not all patients are interested in the new option and ...
Newsweek

HIV Breakthrough as New Injection 89% More Effective Than PrEP

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...
WRAL

Twice-a-year injection reduced risk of HIV infection by 96%, drug company says — more than daily PrEP pill

(CNN) — A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP. ...